Assignee
PROTALIX LTD
IL15 patents
Top patents by PatentIndex Score
US7951557B2May 31, 2011
Human lysosomal proteins from plant cell culture
PROTALIX LTD30 citations94
US9708595B2Jul 18, 2017
Stabilized alpha-galactosidase and uses thereof
PROTALIX LTD4 citations82
US10870842B2Dec 22, 2020
Stabilized alpha-galactosidase and uses thereof
PROTALIX LTD2 citations71
US10280414B2May 7, 2019
Stabilized α-galactosidase and uses thereof
PROTALIX LTD3 citations71
US10087232B2Oct 2, 2018
Use of plant cells expressing a TNFalpha polypeptide inhibitor in therapy
PROTALIX LTD2 citations69
US9603907B2Mar 28, 2017
Dry powder formulations of dNase I
PROTALIX LTD2 citations69
US10000551B2Jun 19, 2018
Chimeric polypeptides, polynucleotides encoding same, cells expressing same and methods of producing same
PROTALIX LTD5 citations68
US11225648B2Jan 18, 2022
Modified DNase and uses thereof
PROTALIX LTD4 citations65
US9220737B2Dec 29, 2015
Plant cell culture expressing human lysosomal proteins and uses thereof
PROTALIX LTD1 citations61
US12385026B2Aug 12, 2025
Stabilized alpha-galactosidase and uses thereof
PROTALIX LTD0 citations60
US11814657B2Nov 14, 2023
Modified DNase and uses thereof
PROTALIX LTD0 citations55
US12194079B2Jan 14, 2025
Therapeutic regimen for the treatment of Fabry using stabilized alpha-galactosidase
PROTALIX LTD0 citations52
US9603906B2Mar 28, 2017
Inhalable liquid formulations of DNase I
PROTALIX LTD0 citations48
US10730925B2Aug 4, 2020
Chimeric polypeptides, polynucleotides encoding same, cells expressing same and methods of producing same
PROTALIX LTD0 citations47
US12385054B2Aug 12, 2025
Removal of constructs from transformed cells
PROTALIX LTD0 citations39